Composition for contraception

Details Composition for contraception Composition for contraception

1996-10-31

1998-10-20

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514173, 514178, 514182, A61K 31565, A61K 3157, A61K 31585

Patent

active

058246673

ABSTRACT:
A combination product for oral contraception is disclosed comprising an estrogen selected from

REFERENCES:
G.B. Melis, et al., Contraception, "A Comparative Study on the Effects of a Monophasic Pill Containing Desogestrel Plus 20 .mu.g Ethinylestradiol, a Triphasic Combination Containing Levonorgestrel and a Monophasic Combination Containign gestrodene on Coagulatory Factors", vol. 43, No. 1,
A. R. Genazzani, et al. (Ed), Progress in Gynecology and Obstetrics, "Multicenter Clinical Trial on the new Oral Contraceptive Containing 20 .mu.g Ethinylestradiol", Chapter 1, pp. 747-756, (1990).
PCT Search Report dated May 12, 1995.
Parke Davis package insert for Loestrin, Jun., 1993.

Affiliated with

Also associated with

Rating

Composition for contraception does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for contraception, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for contraception will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-244489